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One of the immunosuppressive effects of both ultraviolet 
(UV) light and chemical carcinogens is to deplete Langer-
hans cells (LC) from the epidermis, suggesting that these 
cells play an important .role in inducing immune r~sponses ~o 
developing tumors dunng the ~arl.y ph~ses of carCInogenesIs. 
Retinoids such as all-trans-retInOlC aCid (RA) are natural or 
synthetic deriva~ives of ,:itamin A; .~ binds to. nuclear re-
ceptors in the skIn, effectIng transcnptlon of a Wide range of 
genes. Topical application of RA prevents the tumor pro-
moter 12-0-tetradecanoylphorbol-13-acetate (TPA) from 
depleting the densi.ty ofLC in murine epidermis .. In contrast, 
topical RA did not Itself alter the normal LC denSity. RA also 
inhibited the development of TPA-induced immunosup-
pression to a locally applied contact sensitizer. Topical RA 
B oth ultraviolet (UV) light and chemical carcinogens are immunosuppressive, suggesting that inhibition of the skin immune system (SIS) may be important for enabling the development of skin tumors. There has been considerable experimental evidence to support 
this concept [1]. One of the immunosuppressive effects of both UV 
light and chemical carcinogens [2] is a deleterious effect on Langer-
hans cells (LC). Hence the use of biologic modifiers to enhance or 
protect the fu~ct~on of LC d~ring carcinogenesis may be useful for 
reducing the 1I1Cldence of skll1 cancer. We have shown that retl-
noids are useful for protecting some of the functions of LC during 
carcinogenesis . 
LANGERHANS CELLS 
LC are dendritic antigen-presenting cells (APC) that are capable of 
initiating immune responses against a variety of antigens [3] includ-
ing tumors [4]. LC are found in the epidermal layer of mammalian 
skin [5], where they form an evenly distributed network of ce.lls 
with long dendrites that a!most seem ~o touch ea~h oth~r. Despite 
the tightly regulated density of LC wlth1l1 the epldenrus, they are 
migratory cells. LC ~re derived. from .blood-born bo~e marr.ow rre-
cursors that migrate 1I1to the epidermiS where they differentiate 1I1to 
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Abbreviations: 
APC: antigen-presenting cells 
LC: Langerhans cells 
PKC: protein kinase C 
RA: retinoic acid 
SIS: skin immune system 
Thy-l + dEC: Thy-1 + dendritic epidermal cells 
TPA: tetradecanoylphorbol-13-acetate 
also prevented UV light from reducing the density of both 
LC and Thy-l+ dendritic epidermal cells (Thy-l+ dEC) . 
However, the RA treatment did not prevent local immuno-
suppression to the contact sensitizer from developing in re-
sponse to UV irradiation. The reasons for this are unclear; 
however, it is possible that RA does not inhibit some other 
immunosuppressive effect of UV light. Temarotene, a re-
cently developed synthetic retinoid also inhibited UV light 
from reducing the LC and Thy-l + dEC density from murine 
epidermis. Thus part of the anti-carcinogenic activity of reti-
noids may be due to their ability to protect LC during the 
early stages of carcinogenesis. ] Invest Dermatol 99:83S - 86S, 
1992 
LC [6]. LC also migrate from the epidermis to local lymph nodes 
[7]. Within 24 h following application of contact sensitizers to 
mouse skin, antigen-labeled Ia+ dendritic cells have been identified 
in the draining lymph nodes, and it has been shown that these cells 
are able to induce a primary immune response when isolated and 
il~ected into naive mice [8,9]. Thus the number ofLC that migrate 
to local lymph nodes is critical for the induction of immune re-
sponses in the skin. 
THY-1 DENDRITIC CELLS 
Thy~ 1 + dendritic epidermal cells (Thy-1 + dEC) are also present in 
mUrine but not human epidermis [10]. These cells express the ylc5 
T-cell receptor f~r antigen on their cell surface and are hence proba-
bly a subpopulatlon of T lymphocytes [11]. The function of these 
cells has yet to be elucidated. 
CHANGES IN THE SKIN IMMUNE SYSTEM 
DURING CARCINOGENESIS 
A reduction in LC density occurs during the early stages of chemical 
or UV light-induced carcinogenesis [12,13]. Contact sensitizers 
applied locally to chemical carcinogen or UVB exposed skin acti-
vates T sUP1?ressor (Ts) lymphocytes, inducing immunologic toler-
ance [14,15 J. Thus there is good evidence that a reduced LC density 
impairs the immunologic capabilities of the skin. Both UV light and 
chemical carcinogens also alter the function of the LC that remain 
in the epidermis as these cells induce tolerance when conjugated to 
antigen and inoculated into naive mice [16,17] . 
RETINOIDS 
Retinoids are natural or synthetic analogues of vitamin A. They are 
potent biologic modifiers, their mode of action resembling steroid 
hormones as they bind to nuclear receptors, controlling gene ex-
pression. Three nuclear receptors (a, [3, y) have been identified that 
may regulate the transcription of different genes [18]. The major 
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Figure 1. Langerhans cell density in BALB/c mice treated once per week 
with RA and TPA for 4 weeks (e), or HRA : Skh mice treated 5 d per week 
with RA and UV for 4 weeks (A) . Cont, control untreated mice; RA, mice 
treated topically with RA; TPA, mice treated topically with TPA; TPA + 
RA, mice treated topically with TPA and RA; UV, mice irradiated with UV 
light; UV + RA, mice irradiated with UV light and treated topically with 
RA. 
dietary source of vitamin A is beta-carotene, which is metabolically 
converted to all-trans-retinoic acid (RA; tretinoin) and other reti-
noids. Natural retinoids have multiple biologic activities; hence 
synthetic analpgues, with only some functions of natural retinoids, 
have been produced for potential therapeutic use. Temarotene is 
one of these interesting new synthetic retinoids with anti-carcino-
genic properties [19J. 
EFFECTS OF RETINOIDS ON THE SKIN IMMUNE 
SYSTEM DURING CHEMICAL CARCINOGENESIS 
We have recently shown that topical RA prevents the decrease in 
LC density that occurs upon application of the tumor promoter 
12-0-tetradecanoylphorbol-13-acetate (TPA) to BALB/c murine 
skin [20]. In these experiments LC were identified by staining with 
both anti-Ia monoclonal antibodies as well as the cytoplasmic 
enzyme p-glucuronidase in order to ascertain that the observed 
changes were not the result of alterations in surface expression ofIa. 
Mice were treated with 34 nmol RA 24 h and immediately prior to 
application ofTPA. The LC density was reduced by 30% 7 d follow-
ing a single application ofTPA, and this was completely inhibited 
by RA (Fig 1). Four weekly treatments with TPA reduced the LC 
density by 39%, and this was also completely inhibited by RA. RA 
on its own did not influence LC density after 1 week of treatment 
but increased the LC density by 20% after 4 weeks of treatment. 
The functional implications of RA inhibition of TPA-induced 
reduction in LC numbers was examined by applying a contact sensi-
tizer to mice following 4 weekly TPA treatments. TPA reduced the 
contact sensitivity response by 71 % and this was completely inhib-
ited by RA. RA on its own did not alter the contact sensitivity 
response despite the increased LC density in these mice. 
EFFECTS OF RETINOIDS ON THE SKIN IMMUNE 
SYSTEM DURING UV LIGHT - INDUCED 
CARCINOGENESIS 
We have also recently shown that topical RA protects LC from 
being depleted by UV light [21]. In these experiments we used a UV 
source containing UVA (315-400 nm) and UVB (290 -315 nm) 
with any contaminating UVC light being removed with a cellulose 
acetate filter, thus closely resembling solar radiation at the earth's 
surface. Furthermore, rather than giving single high doses of UV 
light to deplete LC, we used daily chronic low doses, thus resem-
bling the exposure that humans receive during their daily lives, 
rather than the large bursts of sunlight to which humans are occa-
sionally subjected. Mice were irradiated with the minimal erythe-
mal dose ofUV light 5 d per week for 4 weeks. This UV procedure 
reduced the density ofLC by about 62%; shorter periods of exposure 
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did not reduce the LC density. In contrast, if the UV source was not 
filtered, including a small amount of contaminating UVC during 
the irradiation, then LC depletion occurred within 3 d, indicating 
the effectiveness of UVC in reducing LC density compared to 
UVB . 
Topical application of RA 24 h prior to each UV irradiation 
completely prevented UV from depleting LC from the epidermis of 
HRA: Skh mice (Fig 1). Similarly, mice fed a diet supplemented 
with the third generation retinoid, temarotene, did not have their 
LC density reduced by UV irradiation. The ability of an oral reti-
noid to inhibit depletion ofLC makes it unlikely that the topical RA 
was acting as a sunscreen, and implies that the protection was related 
to the biologic function of retinoids. This UV irradiation procedure 
also depleted Thy-1 + cells from the epidermis ofHRA-Skh mice by 
about 50%. Both topical RA and oral temarotene protected Thy-1 + 
cells from the effects of UV light. 
However, neither RA nor temarotene protected against the in-
duction of local UV -induced immunosuppression to a contact sen-
sitizer (Fig 2). This contrasts with the ability of RA to protect 
against the development of local TPA-induced immunosuppres-
sion. The ability to immunosuppress RA-treated mice with UV 
light also suggests that the retinoids were not acting as sunscreens, as 
enough UV still penetrated the mice to cause immunosuppression. 
It is possible that either the LC in RA- and UV-treated mice were 
functionally impaired despite their normal density, or that other 
UV-induced immunosuppressive events were not inhibited by RA. 
As RA is able to inhibit TPA-induced immunosuppression, the 
former is unlikely. UV light causes the production of various im-
munosuppressive factors, including cis urocanic acid [22], prosta-
glandin E2 [23], and undefined factors produced by keratinocytes 
[24]; hence it is possible that retinoids do not inhibit the production 
of one or more of these factors . 
These experiments were performed with both albino HRA: Skh-1 
and lightly pigmented HRA : Skh-2 mice, which develop a light tan 
in response to UV irradiation. The same results were obtained using 
each of these mouse strains, indicating that a light tan is unable to 
protect LC from being depleted by UV light. 
In these experiments, daily treatment ofHRA: Skh mice with RA 
alone did not increase the density of local LC, whereas treatment of 
BALB/c mice once per week with the same dose ofRA did increase 
the LC density [20] . This may be due to either the different treat-
ment regimes or the different mouse strains used. 
MECHANISM OF RETINOID INHIBITION 
OF LANGERHANS CELLS DEPLETION BY TPA 
AND UV LIGHT 
The mechanism by which retinoids inhibit TPA and UV-induced 
depletion of LC remains unclear. TP A activates protein kinase C 
(PKC) [25]' and has been demonstrated to activate epidermal PKC 
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Figure .2. Contact sensitivity response in HRA:Skh mice treated 5 d per 
week With RA and UV hght for 4 weeks. Cont, control untreated mice; RA, 
mice treated topica lly with RA; UV, mice irradiated with UV light; UV + 
RA, mice irradiated with UV light and treated topically with RA. 
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[26]. By using monoclonal antibodies specific for PKC, it has been 
shown that mouse LC but not keratinocytes express high levels of 
PKC [27] . Therefore it seems likely that activation ofLC PKC by 
TP A may have initiated migration of LC from the epidermis, re-
ducing the epidermal density of these cells. It is possible that the 
retinoid treatment inhibited this process as one of the biologic mech-
anisms of action of retinoids is to affect PKC [28]. It has also been 
shown that solar irradiation of a human epithelioid cell line induces 
PKC mRNA in a manner similar to tumor promoters [29] . Thus it is 
possible that r~tinoids may interfer.e ",:it~ TPA.- or UV light-
induced activation of PKC on LC, lI1hlbltlng migration of these 
cells from the epidermis. 
SIGNIFICANCE OF EFFECTS OF RETINOIDS ON SKIN 
IMMUNE SYSTEM FOR CARCINOGENESIS 
There is considerable evidence that retinoids are useful for the pre-
vention of cancer. People with a low vitamin A intake have an 
increased risk of skin cancer [30] . Clinical trials have found retinoids 
useful for treatment of cutaneous malignancies [31]. RA has also 
been shown to inhibit the promoter but not the initiator phase of 
carcinogenesis in experimental animals [32]. Thus it is possible that 
the anti-carcinogenic activity of retinoids may partially be due to 
their ability to protect LC during chemical and UV -induced carcino-
genesis . 
SUMMARY AND CONCLUSIONS 
LC and possibly Thy-1+ dEC are likely to be important for the 
induction of immune responses to skin tumors. Their density and 
function is impaired during UV-induced carcinogenesis and the 
promoter phase of chemical carcin~genesis~ suggest~n~ tha~ one .of 
the important steps that occurs dunng carClI10genesls IS an Impair-
ment in local APe. We have found that retinoids inhibit the reduc-
tion in LC density and immunosuppression during the promoter 
phase of chemical carcinogenesis. Retinoids also inhibit LC and 
Thy-1 + dEC deple~ion b.ut not.immunosul?pr~ssion during l?Y -in-
duced carcinogenesIs. It IS pOSSIble that retlI101ds do not 1I1lubit the 
production of other immunosuppressive events that occur in re-
sponse to UV light e~posure. The n:echal:is.m by which retinoids 
inhibit this LC depletion from the epidermiS IS unknown; however, 
it is possible that both TP A and UV light activate PKC on the LC, 
inducing their migration from the epidermis, and retinoids may 
interfere with this process. These studies demonstrate that biologic 
modifiers such as retinoids may be able to modify the function of 
local LC, and this may be useful for both enhancing and suppressing 
the function of these cells. 
REFERENCES 
1. Kripke ML: Immunologic unresponsiveness induced by UV radiation. 
Immunol Rev 80:87 -102, 1984 
2. Halliday GM, Cavanagh LL, Barnetson RStC: Regulation of the skin 
immune system by local antigen presenting cells. Today's Life 
Science 2:26-34, 1990 
3. Stingl G, Katz SI, Clement L, Green I, Shevach EM: Immunologic 
functions of la-bearing epidermal Langerhans cells. J Immunol 
121:2005-2013,1978 
4. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein 
RD: Tumor antigen presentation by murine epidermal cells. J Im-
munoI146:3656-3661,1991 
5. Streilein JW, Grammer SF, Yoshikawa T, Demidem A, Vermeer M: 
Functional dichotomy between Langerhans cells that present anti-
gen to naive and to memory/effector T lymphocytes. Immunol Rev 
117:159-183,1990 
6. Katz SI, Tamaki K, Sachs DH: Epidermal Langerhans cells are derived 
from cells originating in bone marrow. Nature (Lond) 282:324-
327,1979 
7. Silberberg-Sinakin I, Gigli I, Baer RL, Thorbecke GJ: Langerhans 
cells: role in contact hypersensitivity and relationship to lymphoid 
RETINOIDS AND THE SKIN IMMUNE SYSTEM 85S 
dendritic cells and to macrophages. Immunol Rev 53:203 - 232, 
1980 
8. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P: Localiza-
tion of antigen on lymph node dendritic cells after exposure to the 
contact sensitizer fluorescein isothiocyanate. Functional and mor-
phological studies. J Exp Med 166:1654-1667, 1987 
9. Kimber I, Kinnaird A, Peters SW, Mitchell JA: Correlation between 
lymphocyte proliferative responses and dendritic cell migration 
in regional lymph nodes following skin painting with contact-
sensitizing agents. Int Arch Allergy Appl Immunol 93:47 - 53, 
1990 
10. Bergstresser PR, Sullivan S, Streilein JW, Tigelaar RE: Origin and 
function of Thy-l + dendritic epidermal cells in mice. J Invest Der-
matoI85:85S-90S, 1985 
11. Tigelaar RE, Lewis JM, Bergstresser PR: TCR gamma/delta+ den-
dritic epidermal T cells as constituents of skin-associated lymphoid 
tissue. J Invest Dermatol 94:58S - 63S, 1990 
12. Halliday GM, Odling KA, Ruby JC, Muller HK: Suppressor cell acti-
vation and enhanced skin allograft survival after tumor promoter but 
not initiator induced depletion of cutaneous Langerhans cells. 
J Invest Dermatol 90:293 - 297, 1988 
13. Toews GB, Bergstresser PR, Streilein JW: Epidermal Langerhans cell 
density determines whether contact hypersensitivity or unrespon-
siveness follows skin painting with DNFB. J ImmunoI124:445-
453, 1980 
14. Halliday GM, Muller HK: Sensitization through carcinogen-induced 
Langerhans cell-deficient skin activates specific long-lived suppres-
sor cells for both cellular and humoral immunity. Cell Immunol 
109:206-221,1987 
15. Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW: 
Analysis of the mechanism of unresponsiveness produced by haptens 
painted on skin exposed to ultraviolet radiation. J Exp Med 
158:781-794,1983 
16. Cruz PO, Nixon-Fulton JL, Tigelaar RE, Bergstresser PR: Disparate 
effects of in vitro low-dose UVB irradiation on intravenous immuni-
zation with purified epidermal cell subpopulations for the induction 
of contact hypersensitivity. J Invest Dermatol 92:160-165, 1989 
17. Halliday GM, Wood RC, Muller HK: Presentation of antigen to sup-
pressor cells by a dimentylbenz(a)anthracene-resistant, la-positive, 
Thy-I-negative, I-J-restricted epidermal cell. Immunology 69:97-
103,1990 
18. MangelsdorfDJ, Ong ES, DyckJA, Evans RM: Nuclear receptor that 
identifies a novel retinoic acid response pathway. Nature 345:224-
229, 1990 
19. Allen JG, Bloxham DP: The pharmacology and pharmacokinetics of 
the retinoids. Pharmacol Ther 40: 1-27, 1989 
20. Halliday GM, Dickinson JL, Muller HK: Retinoic acid protect Lan-
gerhans' cells from the effects of the tumour promotor 12-0-tetra-
decanoylphorboI13-acetate. Immunology 67:298-302,1989 
21. Ho KK-L, Halliday GM, Barnetson RStC: Topical and oral retinoids 
protect Langerhans' cells and epidermal Thy-1+ cells from being 
depleted by ultraviolet radiation. Immunology 74:425-431,1991 
22. de Fabo EC, Noonan FP: Mechanism of immune suppression by ultra-
Violet irradiation in vivo. 1. Evidence for the existence of a unique 
photoreceptor in skin and its role in photoimmunology. J Exp Med 
157:84-98,1983 
23. Chung H-T, Burnham DK, Roberts LK, Daynes RA: Involvement of 
prostaglandins in the immune alteration caused by the exposure of 
mice to ultraviolet radiation. J Immunol137:2478-2484, 1986 
24. Kim T-Y, Kripke ML, Ullrich SE: Immunosuppression by factors 
released from UV -irradiated epidermal cells: selective effects on the 
generation of contact and delayed hypersensitivity after exposure to 
UVA or UVB radiation. J Invest Dermatol 94:26 - 32, 1990 
25. Nishizuka Y: Studies and perspectives of protein kinase C. Science 
233:305-312,1986 
26. Fisher GJ, Harris VA, Voorhees JJ: Purification and characterization 
of calcium/phospholipid-dependent protein kinase in pig epider-
mis. J Invest Dermatol 89:484-488, 1987 
27. Koyama Y-i, Hachiya T, Hagiwara M, Kobayashi M, Ohashi K, Ho-
shino T, Hidaka H, Marunouchi T: Expression of protein kinase C 
isoenzyme in epidermal Langerhans cells of the mouse. J Invest 
Dermatol 94:677 - 680, 1990 
28. Pailler-Rodde I, Garcin H, Higueret P: Effect of retinoids on protein 
86S HALLIDAY ET AL 
kinase C activity and on the binding characteristics of the tri-iodo-
thyronine nuclear receptor. J Endocrinology 128:245-251, 1991 
29. Peak JG, Woloshak GE, Peak MJ: Enhanced expression of protein 
kinase C gene caused by solar radiation. Photochem Photobiol 
53:395 - 397,1991 
30. Teelmann K: Retinoids: toxicology and teratogenicity to date. Phar-
macol Ther 40:29-43,1989 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
31. Lippman SM, Meyskens FL: Results of the use of vitamin A and reti-
noids in cutaneous malignancies. Pharmacol Ther 40: 1 07 -122, 
1989 
32. Verma AK, Conrad EA, BOlltwell RK: Differential effects of retinoic 
acid and 7,8-benzoflavone on the induction of mouse skin tumors by 
the complete carcinogenesis process and by the initiation-promotion 
regimen. Cancer Res 42:3519 - 3525, 1982 
